Context Therapeutics Inc. (CNTX) Stock Taking Solid Steps Forward, Here’s Why
Context Therapeutics Inc. (CNTX), a clinical-stage biopharmaceutical company, has increased by 3.61% in the premarket trading session. Consequently, CNTX stock is trading at $2.58 at the time of the writing. The increase could be attributed to the new appointments by the company. On Wednesday, CNTX closed the day at $2.49 after plunging 9.12% in the […]